195 related articles for article (PubMed ID: 11322266)
41. [Results of zidovudine treatment of 9 vertically HIV infected children].
Berkefeld I; Fuchs A; Wahn V
Monatsschr Kinderheilkd; 1993 Jun; 141(6):498-504. PubMed ID: 8101636
[TBL] [Abstract][Full Text] [Related]
42. Alternating treatment with didanosine and zidovudine versus either drug alone for the treatment of advanced HIV infection. The Alter Study. Nordic HIV Therapy Group.
Gerstoft J; Melander H; Bruun JN; Pedersen C; Głtzsche PC; Berglund O; Mathiesen L; Skinhłj P; Norrby SR
Scand J Infect Dis; 1997; 29(2):121-8. PubMed ID: 9181646
[TBL] [Abstract][Full Text] [Related]
43. Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence. HIV Trialists' Collaborative Group.
Lancet; 1999 Jun; 353(9169):2014-25. PubMed ID: 10376616
[TBL] [Abstract][Full Text] [Related]
44. Didanosine once daily: an overview.
Youle M
Antivir Ther; 1998; 3 Suppl 4():35-7. PubMed ID: 10723507
[TBL] [Abstract][Full Text] [Related]
45. Italian multicentre study of didanosine compassionate use in advanced HIV infection. Italian BMS-906 Study Group.
d'Arminio Monforte A; Musicco M; Galli M; Paga C; La Regina A; Lazzarin A; Angarano G; Milazzo F; Gritti F; Arlotti M; Mazzotta F; Visco G; Aiuti F; Moroni M
Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):135-42. PubMed ID: 9105840
[TBL] [Abstract][Full Text] [Related]
46. Comparative evaluation of cefadroxil and cephalexin in children and adolescents with pyodermas. Cefadroxil Once Daily Pyoderma Study Group.
Linder CW; Nelson K; Paryani S; Stallworth JR; Blumer JL
Clin Ther; 1993; 15(1):46-56. PubMed ID: 8458054
[TBL] [Abstract][Full Text] [Related]
47. The CCR5Delta32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment.
Barroga CF; Raskino C; Fangon MC; Palumbo PE; Baker CJ; Englund JA; Spector SA
J Infect Dis; 2000 Aug; 182(2):413-9. PubMed ID: 10915070
[TBL] [Abstract][Full Text] [Related]
48. Switching from zidovudine to didanosine in patients with symptomatic HIV infection and disease progression. ddI Iberian Study Group.
Gatell JM; González-Lahoz J; Clotet B; Antunes F; Kasparova L; Gil-Aguado A; Saballs P; Santamaria JM; Podzamczer D; Miro JM; Jou A; Verdejo J; Doroana M; Thomis J
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jul; 12(3):249-58. PubMed ID: 8673528
[TBL] [Abstract][Full Text] [Related]
49. A dose comparison study of didanosine in patients with very advanced HIV infection who are intolerant to or clinically deteriorate on zidovudine. German ddI Trial Group.
Jablonowski H; Arasteh K; Staszewski S; Ruf B; Stellbrink HJ; Schrappe M; Stoehr A; Haase W; Schomaker U; von Eisenhart Rothe B
AIDS; 1995 May; 9(5):463-9. PubMed ID: 7639971
[TBL] [Abstract][Full Text] [Related]
50. Low-dose zidovudine in children with an human immunodeficiency virus type 1 infection acquired in the perinatal period.
Blanche S; Duliege AM; Navarette MS; Tardieu M; Debré M; Rouzioux C; Seldrup J; Kouzan S; Griscelli C
Pediatrics; 1991 Aug; 88(2):364-70. PubMed ID: 1861941
[TBL] [Abstract][Full Text] [Related]
51. A simplified weight-based method for pediatric drug dosing for zidovudine and didanosine in resource-limited settings.
Weidle PJ; Abrams EJ; Gvetadze R; Rivadeneira E; Kline MW
Pediatr Infect Dis J; 2006 Jan; 25(1):59-64. PubMed ID: 16395105
[TBL] [Abstract][Full Text] [Related]
52. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial.
Gordon M; Bihari B; Goosby E; Gorter R; Greco M; Guralnik M; Mimura T; Rudinicki V; Wong R; Kaneko Y
J Med; 1998; 29(5-6):305-30. PubMed ID: 10503166
[TBL] [Abstract][Full Text] [Related]
53. [The treatment of 12 HIV-infected children with zidovudine].
Scherpbier HJ; Prakken AB; de Graeff-Meeder ER; van den Berg H
Ned Tijdschr Geneeskd; 1993 Aug; 137(32):1610-3. PubMed ID: 8366963
[TBL] [Abstract][Full Text] [Related]
54. Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection.
Collier AC; Coombs RW; Fischl MA; Skolnik PR; Northfelt D; Boutin P; Hooper CJ; Kaplan LD; Volberding PA; Davis LG; Henrard DR; Weller S; Corey L
Ann Intern Med; 1993 Oct; 119(8):786-93. PubMed ID: 8379600
[TBL] [Abstract][Full Text] [Related]
55. Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infection.
Sei S; Sandelli SL; Theofan G; Ratto-Kim S; Kumagai M; Loomis-Price LD; Cox JH; Jarosinski P; Walsek CM; Brouwers P; Venzon DJ; Xu J; Pizzo PA; Moss RB; Robb ML; Wood LV
J Infect Dis; 1999 Sep; 180(3):626-40. PubMed ID: 10438349
[TBL] [Abstract][Full Text] [Related]
56. Didanosine compared with continued zidovudine therapy for HIV-infected patients with 200 to 500 CD4 cells/mm3. A double-blind, randomized, controlled trial. Canadian HIV Trials Network Protocol 002 Study Group.
Montaner JS; Schechter MT; Rachlis A; Gill J; Beaulieu R; Tsoukas C; Raboud J; Cameron B; Salomon H; Dunkle L; Smaldone L; Wainberg MA
Ann Intern Med; 1995 Oct; 123(8):561-71. PubMed ID: 7677296
[TBL] [Abstract][Full Text] [Related]
57. Didanosine. An update on its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV disease.
Perry CM; Balfour JA
Drugs; 1996 Dec; 52(6):928-62. PubMed ID: 8957161
[TBL] [Abstract][Full Text] [Related]
58. Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials Group.
Dolin R; Amato DA; Fischl MA; Pettinelli C; Beltangady M; Liou SH; Brown MJ; Cross AP; Hirsch MS; Hardy WD
Arch Intern Med; 1995 May; 155(9):961-74. PubMed ID: 7726705
[TBL] [Abstract][Full Text] [Related]
59. A randomized trial (ISS 902) of didanosine versus zidovudine in previously untreated patients with mildly symptomatic human immunodeficiency virus infection.
Floridia M; Vella S; Seeber AC; Tomino C; Fragola V; Weimer LE; Ricciardulli D; Milazzo F; Gritti FM; Mazzotta F; Ranieri S; Chiodo F; Moroni M; Cargnel A; Bassetti D; Giannini V; Cremoni L; Concia E; Sinicco A; Carosi G; Alberici F; Dianzani F
J Infect Dis; 1997 Feb; 175(2):255-64. PubMed ID: 9203645
[TBL] [Abstract][Full Text] [Related]
60. Long-term follow-up of didanosine administered orally twice daily to patients with advanced human immunodeficiency virus infection and hematologic intolerance of zidovudine.
Allan JD; Connolly KJ; Fitch H; Jackson-Pope L; McLaren C; Canetta R; Groopman JE
Clin Infect Dis; 1993 Feb; 16 Suppl 1():S46-51. PubMed ID: 8425019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
